pembrolizumab,lenvatinib,cabozantinib,nivolumab
merck,bms
['nivolumab', 'pembro', 'rcc,(-irccs),(-srcc),(-urcc)', 'cabozantinib', 'renal,(-adrenal)', 'lenva', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'keynote-b61', 'nivo']
io + tki in non clear cell rcc. best of journals: outstanding article selections by #gu23 
Oncólogo Clínico staff @IAF_Fleming. Miembro @SelnetH2020 @aaoncoclinica. Interesado en #GUcsm. #clinicaltrials. #Immunotherapy #PrecisionMedicine #oncoalert